Whole Body Health Sale

Life Extension Magazine

LE Magazine November 2005
image

A Little-Known Fact: Alcohol is a Carcinogen!

By Dale Kiefer
References

1. Available at: http://www.ias.org.uk/factsheets/health.pdf. Accessed August 29, 2005.

2. Available at: http://www.who.int/whr/ 2002/en/. Accessed August 29, 2005.

3. Available at: http://www.wrongdiagnosis.com/ a/alcohol_abuse/prevalence-types.htm. Accessed August 29, 2005.

4. Available at: http://www.intelihealth.com/ IH/ihtIH/WSIHW000/9339/9422.html.Accessed August 29, 2005.

5. Available at: http://www.niehs.nih.gov/oc/ news/9thROC.htm. Accessed August 29, 2005.

6. Diaz V, Cumsille MA, Bevilacqua JA. Alcohol and hemorrhagic stroke in Santiago, Chile. A case-control study. Neuroepidemiology. 2003 Nov-Dec;22(6):339-44.

7. Available at: http://www.emedicine.com/ NEURO/topic278.htm. Accessed August 29, 2005.

8. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/000714.htm.Accessed August 29, 2005.

9. Available at: http://alcoholism.about.com/ gi/dynamic/offsite.htm?site=http://www.niaaa.nih.gov/. Accessed August 29, 2005.

10. Lieber CS. Alcohol and health: a drink a day won’t keep the doctor away. Cleve Clin J Med. 2003 Nov;70(11):945-3.

11. Rimm E. Alcohol and cardiovascular disease. Curr Atheroscler Rep. 2000 Nov;2(6):529-35.

12. Altieri A, Garavello W, Bosetti C, Gallus S, Vecchia CL. Alcohol consumption and risk of laryngeal cancer. Oral Oncol. 2005 May 28.

13. Randi G, Altieri A, Gallus S, et al. History of cirrhosis and risk of digestive tract neoplasms. Ann Oncol. 2005 May 26.

14. Morita M, Oyama T, Kagawa N, et al. Expression of aldehyde dehydrogenase 2 in the normal esophageal epithelium and alcohol consumption in patients with esophageal cancer. Front Biosci. 2005 Sep 1;10:2319-24.

15. Chang ET, Hedelin M, Adami HO, Gronberg H, Balter KA. Alcohol drinking and risk of localized versus advanced and sporadic versus familial prostate cancer in Sweden. Cancer Causes Control. 2005 Apr;16(3):275-84.

16. Voigt MD. Alcohol in hepatocellular cancer. Clin Liver Dis. 2005 Feb;9(1):151-69.

17. Dumitrescu RG, Shields PG. The etiology of alcohol-induced breast cancer. Alcohol. 2005 Apr;35(3):213-35.

18. Martinez ME. Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent Results Cancer Res. 2005;166:177-211.

19. Kim DJ, Yoon SJ, Lee HP, Choi BM, Go HJ. The effects of alcohol hangover on cognitive functions in healthy subjects. Int J Neurosci. 2003 Apr;113(4):581-94.

20. McKinney A, Coyle K. Next day effects of a normal night’s drinking on memory and psychomotor performance. Alcohol Alcohol. 2004 Nov;39(6):509-13.

21. Kim DJ, Kim W, Yoon SJ, et al. Effects of alcohol hangover on cytokine production in healthy subjects. Alcohol. 2003 Nov;31(3):167-70.

22. Nicolaou C, Chatzipanagiotou S, Tzivos D, et al. Serum cytokine concentrations in alcohol-dependent individuals without liver disease. Alcohol. 2004 Apr;32(3):243-7.

23. Lieber CS. Alcohol and the liver: metabolism of alcohol and its role in hepatic and extrahepatic diseases. Mt Sinai J Med. 2000 Jan;67(1):84-94.

24. Umulis DM, Gurmen NM, Singh P, Fogler HS. A physiologically based model for ethanol and acetaldehyde metabolism in human beings. Alcohol. 2005 Jan;35(1):3-12.

25. Lieber CS. ALCOHOL: its metabolism and interaction with nutrients. Annu Rev Nutr. 2000;20:395-430.

26. Quintans LN, Castro GD, Castro JA. Oxidation of ethanol to acetaldehyde and free radicals by rat testicular microsomes. Arch Toxicol. 2005 Jan;79(1):25-30.

27. Castro GD, Delgado de Layno AM, Costantini MH, Castro JA. Rat ventral prostate microsomal biotransformation of ethanol to acetaldehyde and 1-hydroxyethyl radicals: its potential contribution to prostate tumor promotion. Teratog Carcinog Mutagen. 2002;22(5):335-41.

28. Sakurai K, Stoyanovsky DA, Fujimoto Y, Cederbaum AI. Mitochondrial permeability transition induced by 1-hydroxyethyl radical. Free Radic Biol Med. 2000 Jan 15;28(2):273-80.

29. Worrall S, de Jersey J, Wilce PA. Comparison of the formation of proteins modified by direct and indirect ethanol metabolites in the liver and blood of rats fed the Lieber-DeCarli liquid diet. Alcohol Alcohol. 2000 Mar;35(2):164-70.

30. Lieber CS. Relationships between nutrition, alcohol use, and liver disease. Alcohol Res Health. 2003;27(3):220-31.

31. Lieber CS. The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. Drug Metab Rev. 2004 Oct;36(3-4):511-29.

32. Lieber CS. CYP2E1: from ASH to NASH. Hepatol Res. 2004 Jan;28(1):1-11.

33. Kovacic P, Cooksy AL. Role of diacetyl metabolite in alcohol toxicity and addiction via electron transfer and oxidative stress. Arch Toxicol. 2005 Mar;79(3):123-8.

34. Frezza M, di Padova C, Pozzato G, et al. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990 Jan 11;322(2):95-9.

35. Mann RE, Smart RG, Govoni R. The epidemiology of alcoholic liver disease. Alcohol Res Health. 2003;27(3):209-19.

36. Tuyns AJ, Pequignot G. Greater risk of ascitic cirrhosis in females in relation to alcohol consumption. Int J Epidemiol. 1984 Mar;13(1):53-7.

37. Becker PU, Deis A, Sorensen TI, et al. Alcohol intake and risk of liver disease—significance of gender. A population study. Ugeskr Laeger. 1997 Jun 9;159(24):3782-6.

38. Luo HR, Zhang YP. Aldehyde dehydrogenase (ALDH2) polymorphism and drinking behavior. Yi Chuan. 2004 Mar;26(2):263-6.

39. Yamauchi M, Maezawa Y, Mizuhara Y, et al. Polymorphisms in alcohol metabolizing enzyme genes and alcoholic cirrhosis in Japanese patients: a multivariate analysis. Hepatology. 1995 Oct;22(4 Pt 1):1136-42.

40. Stranges S, Freudenheim JL, Muti P, et al. Greater hepatic vulnerability after alcohol intake in African Americans compared with Caucasians: a population-based study. J Natl Med Assoc. 2004 Sep;96(9):1185-92.

41. Lieber CS. Biochemical factors in alcoholic liver disease. Semin Liver Dis. 1993 May;13(2):136-53.

42. Masalkar PD, Abhang SA. Oxidative stress and antioxidant status in patients with alcoholic liver disease. Clin Chim Acta. 2005 May;355(1-2):61-5.

43. Ryle PR, Thomson AD. Nutrition and vitamins in alcoholism. Contemp Issues Clin Biochem. 1984;1:188-224.

44. Minino AM, Arias E, Kochanek KD, Murphy SL, Smith BL. Deaths: final data for 2000. Natl Vital Stat Rep. 2002 Sep 16;50(15):1-119.

45. Theruvathu JA, Jaruga P, Nath RG, Dizdaroglu M, Brooks PJ. Polyamines stimulate the formation of mutagenic 1,N2-propanodeoxyguanosine adducts from acetaldehyde. Nucleic Acids Res. 2005;33(11):3513-20.

46. Lao Y, Hecht SS. Synthesis and properties of an acetaldehyde-derived oligonucleotide interstrand cross-link. Chem Res Toxicol. 2005 Apr;18(4):711-21.

47. Poschl G, Seitz HK. Alcohol and cancer. Alcohol Alcohol. 2004 May;39(3):155-65.

48. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol. 2004 Aug;34(1):9-19.

49. Marzullo L. An update of N-acetylcysteine treatment for acute acetaminophen toxicity in children. Curr Opin Pediatr. 2005 Apr;17(2):239-45.

50. Vina J, Perez C, Furukawa T, Palacin M, Vina JR. Effect of oral glutathione on hepatic glutathione levels in rats and mice. Br J Nutr. 1989 Nov;62(3):683-91.

51. Aw TY, Wierzbicka G, Jones DP. Oral glutathione increases tissue glutathione in vivo. Chem Biol Interact. 1991;80(1):89-97.

52. Hancock RD, Viola R. Improving the nutritional value of crops through enhancement of L-ascorbic acid (vitamin C) content: rationale and biotechnological opportunities. J Agric Food Chem. 2005 Jun 29;53(13):5248-57.

53. Zhou JF, Chen P. Studies on the oxidative stress in alcohol abusers in China. Biomed Environ Sci. 2001 Sep;14(3):180-8.

54. Devasagayam TP, Tilak JC, Boloor KK, et al. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004 Oct;52:794-804.

55. Sanchez-Moreno C, Paniagua M, Madrid A, Martin A. Protective effect of vitamin C against the ethanol mediated toxic effects on human brain glial cells. J Nutr Biochem. 2003 Oct;14(10):606-13.

56. Zhang F, Yin W, Chen J. Apoptosis in cerebral ischemia: executional and regulatory signaling mechanisms. Neurol Res. 2004 Dec;26(8):835-45.

57. Wang X, Qu WD, Ya S, et al. Effects of alcohol on the expression of heat shock protein 70 and super microstructure of astrocytes in rat embryonic brain. Wei Sheng Yan Jiu. 2005 Mar;34(2):158-60.

58. Schneider C. Chemistry and biology of vitamin E. Mol Nutr Food Res. 2005 Jan;49(1):7-30.

59. Huang J, May JM. Ascorbic acid spares alpha-tocopherol and prevents lipid peroxidation in cultured H4IIE liver cells. Mol Cell Biochem. 2003 May;247(1-2):171-6.

60. Halpner AD, Handelman GJ, Harris JM, Belmont CA, Blumberg JB. Protection by vitamin C of loss of vitamin E in cultured rat hepatocytes. Arch Biochem Biophys. 1998 Nov 15;359(2):305-9.

61. May JM, Qu ZC, Mendiratta S. Protection and recycling of alpha-tocopherol in human erythrocytes by intracellular ascorbic acid. Arch Biochem Biophys. 1998 Jan 15;349(2):281-9.

62. Prakash S, Joshi YK. Assessment of micronutrient antioxidants, total antioxidant capacity and lipid peroxidation levels in liver cirrhosis. Asia Pac J Clin Nutr. 2004;13(Suppl):S110.

63. McDonough KH. Antioxidant nutrients and alcohol. Toxicology. 2003 Jul 15;189(1-2):89-97.

64. Gutteridge JM. The membrane effects of vitamin E, cholesterol and their acetates on peroxidative susceptibility. Res Commun Chem Pathol Pharmacol. 1978 Dec;22(3):563-72.

65. Waluga M, Hartleb M. Alcoholic liver disease. Wiad Lek. 2003;56(1-2):61-70.

66. Mansouri A, Demeilliers C, Amsellen S, Pessayre D, Fromenty B. Acute ethanol administration oxidatively damages and depletes mitochondrial dna in mouse liver, brain, heart, and skeletal muscles: protective effects of antioxidants. J Pharmacol Exp Ther. 2001 Aug;298(2):737-43.

67. Martin PR, Singleton CK, Hiller-Sturmhofel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health. 2003;27(2):134-42.

68. Betrosian AP, Thireos E, Toutouzas K, et al. Occidental beriberi and sudden death. Am J Med Sci. 2004 May;327(5):250-2.

69. Maschke M, Weber J, Bonnet U, et al. Vermal atrophy of alcoholics correlate with serum thiamine levels but not with dentate iron concentrations as estimated by MRI. J Neurol. 2005 Jun;252(6):704-11.

70. Stracke H, Hammes HP, Werkmann D, et al. Efficacy of benfotiamine versus thiamine on function and glycation products of peripheral nerves in diabetic rats. Exp Clin Endocrinol Diabetes. 2001;109(6):330-6.

71. Netzel M, Ziems M, Jung KH, et al. Effect of high-dosed thiamine hydrochloride and S-benzoyl-thiamine-O-monophosphate on thiamine-status after chronic ethanol administration. Biofactors. 2000;11(1-2):111-3.

72. Ayazpoor U. Chronic alcohol abuse. Benfotiamine in alcohol damage is a must. MMW Fortschr Med. 2001 Apr 19;143(16):53.

73. Egner PA, Munoz A, Kensler TW. Chemoprevention with chlorophyllin in individuals exposed to dietary aflatoxin. Mutat Res. 2003 Feb;523-524:209-16.

74. Kensler TW, Egner PA, Wang JB, et al. Strategies for chemoprevention of liver cancer. Eur J Cancer Prev. 2002 Aug;11 Suppl 2S58-S64.

75. Kamat JP, Boloor KK, Devasagayam TP. Chlorophyllin as an effective antioxidant against membrane damage in vitro and ex vivo. Biochim Biophys Acta. 2000 Sep 27;1487(2-3):113-27.

76. Egner PA, Wang JB, Zhu YR, et al. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer. Proc Natl Acad Sci USA. 2001 Dec 4;98(25):14601-6.

77. Della CC, Morichetti E, Intorre L, et al. Biochemical and genetic interactions of two commercial pesticides with the monooxygenase system and chlorophyllin. J Environ Pathol Toxicol Oncol. 1996;15(1):21-8.

78. Sarkar D, Sharma A, Talukder G. Differential protection of chlorophyllin against clastogenic effects of chromium and chlordane in mouse bone marrow in vivo. Mutat Res. 1993 Jan;301(1):33-8.

79. Gentile JM, Rahimi S, Zwiesler J, Gentile GJ, Ferguson LR. Effect of selected antimutagens on the genotoxicity of antitumor agents. Mutat Res. 1998 Jun 18;402(1-2):289-98.

80. Cho YS, Kim BY, Lee ST, Surh YJ, Chung AS. Chemopreventive effect of chlorophyllin on mutagenicity and cytotoxicity of 6-sulfooxymethylbenzo[a]pyrene. Cancer Lett. 1996 Oct 22;107(2):223-8.

81. Bagchi D, Bagchi M, Stohs S, et al. Cellular protection with proanthocyanidins derived from grape seeds. Ann NY Acad Sci. 2002 May;957:260-70.

82. Natella F, Belelli F, Gentili V, Ursini F, Scaccini C. Grape seed proanthocyanidins prevent plasma postprandial oxidative stress in humans. J Agric Food Chem. 2002 Dec 18;50(26):7720-5.

83. Ray SD, Lam TS, Rotollo JA, et al. Oxidative stress is the master operator of drug and chemically-induced programmed and unprogrammed cell death: Implications of natural antioxidants in vivo. Biofactors. 2004;21(1-4):223-32.

84. Ariga T. The antioxidative function, preventive action on disease and utilization of proanthocyanidins. Biofactors. 2004;21(1-4):197-201.

85. Katiyar SK. Silymarin and skin cancer prevention: anti-inflammatory, antioxidant and immunomodulatory effects (Review). Int J Oncol. 2005 Jan;26(1):169-76.

86. Lahiri-Chatterjee M, Katiyar SK, Mohan RR, Agarwal R. A flavonoid antioxidant, silymarin, affords exceptionally high protection against tumor promotion in the SENCAR mouse skin tumorigenesis model. Cancer Res. 1999 Feb 1;59(3):622-32.

87. Katiyar SK, Roy AM, Baliga MS. Silymarin induces apoptosis primarily through a p53-dependent pathway involving Bcl-2/Bax, cytochrome c release, and caspase activation. Mol Cancer Ther. 2005 Feb;4(2):207-16.

88. Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R. Silibinin strongly inhibits growth and survival of human endothelial cells via cell cycle arrest and downregulation of survivin, Akt and NF-kappaB: implications for angioprevention and antiangiogenic therapy. Oncogene. 2005 Feb 10;24(7):1188-202.

89. Mallikarjuna G, Dhanalakshmi S, Singh RP, Agarwal C, Agarwal R. Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling. Cancer Res. 2004 Sep 1;64(17):6349-56.

90. Singh RP, Agarwal R. Flavonoid antioxidant silymarin and skin cancer. Antioxid Redox Signal. 2002 Aug;4(4):655-63.

91. Singh RP, Agarwal R. A cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer. Mutat Res. 2004 Nov 2;555(1-2):21-32.

92. Chu SC, Chiou HL, Chen PN, Yang SF, Hsieh YS. Silibinin inhibits the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Mol Carcinog. 2004 Jul;40(3):143-9.

93. Tyagi A, Agarwal C, Harrison G, Glode LM, Agarwal R. Silibinin causes cell cycle arrest and apoptosis in human bladder transitional cell carcinoma cells by regulating CDKI-CDK-cyclin cascade, and caspase 3 and PARP cleavages. Carcinogenesis. 2004 Sep;25(9):1711-20.

94. Ferenci P, Dragosics B, Dittrich H, et al. Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver. J Hepatol. 1989 Jul;9(1):105-13.

95. Tasduq SA, Peerzada K, Koul S, Bhat R, Johri RK. Biochemical manifestations of anti-tuberculosis drugs induced hepatotoxicity and the effect of silymarin. Hepatol Res. 2005 Mar;31(3):132-5.

96. Lieber CS, Leo MA, Cao Q, Ren C, DeCarli LM. Silymarin retards the progression of alcohol-induced hepatic fibrosis in baboons. J Clin Gastroenterol. 2003 Oct;37(4):336-9.

97. Luper S. A review of plants used in the treatment of liver disease: part 1. Altern Med Rev. 1998 Dec;3(6):410-21.

98. Singh V, Kapoor NK, Dhawan BN. Effect of picroliv on protein and nucleic acid synthesis. Indian J Exp Biol. 1992 Jan;30(1):68-9.

99. Saraswat B, Visen PK, Patnaik GK, Dhawan BN. Ex vivo and in vivo investigations of picroliv from Picrorhiza kurroa in an alcohol intoxication model in rats. J Ethnopharmacol. 1999 Sep;66(3):263-9.

100. Rajeshkumar NV, Kuttan R. Modulation of carcinogenic response and antioxidant enzymes of rats administered with 1,2-dimethylhydrazine by Picroliv. Cancer Lett. 2003 Mar 10;191(2):137-43.

101. Vaidya AB, Antarkar DS, Doshi JC, et al. Picrorhiza kurroa (Kutaki) Royle ex Benth as a hepatoprotective agent—experimental & clinical studies. J Postgrad Med. 1996 Oct;42(4):105-8.

102. Rastogi R, Saksena S, Garg NK, et al. Picroliv protects against alcohol-induced chronic hepatotoxicity in rats. Planta Med. 1996 Jun;62(3):283-5.

103. Visen PK, Saraswat B, Dhawan BN. Curative effect of picroliv on primary cultured rat hepatocytes against different hepatotoxins: an in vitro study. J Pharmacol Toxicol Methods. 1998 Oct;40(3):173-9.

104. Seth P, Sundar SV, Seth RK, et al. Picroliv modulates antioxidant status and down-regulates AP1 transcription factor after hemorrhage and resuscitation. Shock. 2003 Feb;19(2):169-75.

105. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 2004;22(3):169-88.

106. de la Lastra CA, Villegas I. Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Mol Nutr Food Res. 2005 May;49(5):405-30.

107. Jang M, Cai L, Udeani GO, et al. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science. 1997 Jan 10;275(5297):218-20.

108. Markham KR, Mitchell KA. The mis-identification of the major antioxidant flavonoids in young barley (Hordeum vulgare) leaves. Z Naturforsch [C]. 2003 Jan;58(1-2):53-6.

109. Arimoto T, Ichinose T, Yoshikawa T, Shibamoto T. Effect of the natural antioxidant 2”-O-glycosylisovitexin on superoxide and hydroxyl radical generation. Food Chem Toxicol. 2000 Sep;38(9):849-52.

110. Yu YM, Wu CH, Tseng YH, Tsai CE, Chang WC. Antioxidative and hypolipidemic effects of barley leaf essence in a rabbit model of atherosclerosis. Jpn J Pharmacol. 2002 Jun;89(2):142-8.

111. Yu YM, Chang WC, Chang CT, Hsieh CL, Tsai CE. Effects of young barley leaf extract and antioxidative vitamins on LDL oxidation and free radical scavenging activities in type 2 diabetes. Diabetes Metab. 2002 Apr;28(2):107-14.